Pliant Therapeutics, Inc. (PLRX) P/S ratio

P/S ratio · fiscal 2022
83.9×

The P/S ratio of Pliant Therapeutics, Inc. (PLRX) was 83.9× at the end of fiscal 2022 (December 31, 2022). That is 31.2% higher than the 63.9× of fiscal 2021. Figures as of 18 Nov 2026, 11:50 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/S ratio, fiscal 2022
83.9×
Change on fiscal 2021
+31.2%
Highest on record
83.9×fiscal 2022
Lowest on record
11.6×fiscal 2020
Fiscal years on record
32020–2022

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Pliant Therapeutics, Inc. P/S ratio, in more detail

Across the 3 fiscal year-ends on record (2020–2022), the highest was 83.9× in fiscal 2022 and the lowest 11.6× in fiscal 2020.

History · 3 fiscal years

P/S ratio at each fiscal year-end

Pliant Therapeutics, Inc. P/S ratio, year by year

Pliant Therapeutics, Inc. (PLRX) P/S ratio by fiscal year
Fiscal yearP/S ratioChangeYear endedShare price at year-endRevenue per share
2025——$1.22—
2024——$13.17—
2023——$18.11$0.03
202283.9× 31.2% up$19.33$0.23
202163.9× 451.1% up$13.50$0.21
202011.6×—$22.72$1.96
2019———$35.14

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

How to read it

It prices each unit of sales and still works when there is no profit; what counts as high depends on the margin those sales earn.

More on PLRX

Pliant Therapeutics, Inc., figure by figure

Pliant Therapeutics, Inc. (PLRX) overview: price, valuation and scorecard

Pliant Therapeutics, Inc. P/S ratio: questions and answers

What is Pliant Therapeutics, Inc.'s P/S ratio?

The P/S ratio of Pliant Therapeutics, Inc. (PLRX) was 83.9× at the end of fiscal 2022 (December 31, 2022). That is 31.2% higher than the 63.9× of fiscal 2021.

What are the highest and lowest P/S ratio figures on record for Pliant Therapeutics, Inc.?

Across the 3 fiscal year-ends on record (2020–2022), the highest was 83.9× in fiscal 2022 and the lowest 11.6× in fiscal 2020.

How is Pliant Therapeutics, Inc.'s P/S ratio calculated?

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end. For Pliant Therapeutics, Inc. it is on record here for 3 fiscal years, 2020 to 2022.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Pliant Therapeutics, Inc. (PLRX) P/S ratio”, data as of 18 November 2026. https://funkfolio.com/stock/PLRX/ps-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.